Approval · Notice of Compliance 366 · 2002
CLASTEON: Notice of Compliance 366
Issued May 1, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 366
- Date
- May 1, 2002
- Company
- Abiogen Pharma S.P.A
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Bone metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLASTEON | 02245829 | — |
| CLASTEON | 02245828 | Marketed |
Medicinal ingredients
- CLODRONATE DISODIUM 30 MG per ML
- CLODRONATE DISODIUM 400 MG per CAP